Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 75.00 | 89.00 | 0.8427 | 0.8023 | |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 5 | 156.25 | 28.48 | 53.00 | 89.00 | 0.5955 | 0.4591 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 5 | 156.25 | 28.48 | 160.00 | 89.00 | 1.7978 | 1.8575 |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 5 | 156.25 | 28.48 | 111.00 | 89.00 | 1.2472 | 1.2876 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 5 | 156.25 | 28.48 | 59.00 | 89.00 | 0.6629 | 0.5575 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 5 | 156.25 | 28.48 | 52.00 | 89.00 | 0.5843 | 0.4423 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 149.00 | 89.00 | 1.6742 | 1.7363 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 98.00 | 89.00 | 1.1011 | 1.1207 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 169.00 | 242.00 | 0.6984 | 0.2786 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 228.00 | 242.00 | 0.9422 | 0.8569 | |
| SK-BR-3 | Etoposide | 10 | uM | 5 | 312.50 | 138.75 | 165.00 | 242.00 | 0.6818 | 0.2410 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 158.00 | 242.00 | 0.6529 | 0.1757 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 336.00 | 242.00 | 1.3884 | 2.0104 | |
| SK-BR-3 | Etoposide | 1 | uM | 5 | 312.50 | 138.75 | 171.00 | 242.00 | 0.7066 | 0.2975 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 5 | 312.50 | 138.75 | 288.00 | 242.00 | 1.1901 | 1.4843 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 5 | 312.50 | 138.75 | 231.00 | 242.00 | 0.9546 | 0.8874 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 5 | 312.50 | 138.75 | 250.00 | 242.00 | 1.0331 | 1.0827 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 5 | 312.50 | 138.75 | 224.00 | 242.00 | 0.9256 | 0.8164 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 5 | 312.50 | 138.75 | 280.00 | 242.00 | 1.1570 | 1.3986 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 244.00 | 242.00 | 1.0083 | 1.0206 | |
| SK-BR-3 | Etoposide | 0.1 | uM | 5 | 312.50 | 138.75 | 322.00 | 242.00 | 1.3306 | 1.8549 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 5 | 312.50 | 138.75 | 243.00 | 242.00 | 1.0041 | 1.0103 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 5 | 312.50 | 138.75 | 292.00 | 242.00 | 1.2066 | 1.5274 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 5 | 312.50 | 138.75 | 248.00 | 242.00 | 1.0248 | 1.0620 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 5 | 312.50 | 138.75 | 251.00 | 242.00 | 1.0372 | 1.0931 |